LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
NUTF2P3-001 | miR-3923 | KRAS | KRAS;C-K-RAS;CFC2;K-RAS2A;K-RAS2B;K-RAS4A;K-RAS4B;KI-RAS;KRAS1;KRAS2;NS;NS3;RASK2 | details
Natural killer cell mediated cytotoxicity;MAPK signaling pathway;ErbB signaling pathway;Chemokine signaling pathway;PI3K-Akt signaling pathway;Insulin signaling pathway;Hepatitis C;Long-term potentiation;Progesterone-mediated oocyte maturation;Dorso-ventral axis formation;Axon guidance;Endometrial cancer;Regulation of actin cytoskeleton;VEGF signaling pathway;Long-term depression;Estrogen signaling pathway;Cholinergic synapse;Melanogenesis;Hepatitis B;Viral carcinogenesis;Tight junction;Neurotrophin signaling pathway;GnRH signaling pathway;Gap junction;Glioma;T cell receptor signaling pathway; Alcoholism;Prostate cancer;Serotonergic synapse;Bladder cancer;Non-small cell lung cancer;Chronic myeloid leukemia;HTLV-I infection;B cell receptor signaling pathway;Pathways in cancer;Aldosterone-regulated sodium reabsorption;Colorectal cancer;Melanoma;Acute myeloid leukemia;Proteoglycans in cancer;Pancreatic cancer;Renal cell carcinoma;Thyroid cancer;Fc epsilon RI signaling pathway
|
details
Hence, our data provide a new lncRNA-mediated regulatory mechanism for the tumor oncogene KRAS and implicate that lncRNA-NUTF2P3-001 and miR-3923 can be applied as novel predictors and therapeutic targets for pancreatic cancer.
|
details
Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway
|
Pancreatic Cancer | Oncotarget | 26755660 |